Week in review: Demodex blepharitis treatment, gender and grand rounds participation, statins and OAG risk
- Posted on: Jul 28 2023
- Leave a response
The first blepharitis treatment targeting Demodex mites is approved, women ask fewer questions during ophthalmology grand rounds than men, short-term statin use does not increase glaucoma risk, and the TEPEZZA label adds warnings about hearing-related events.
Source: AAO
Posted in: Uncategorized
